Tumour-specific CD8<sup>+</sup> T cells that attack tumour cells directly form the core of antitumor immunity, yet chronic antigenic stimulation drives functional impairment and exhaustion that constrain treatment responsiveness. The gene discussed is CD8A; the disease is neoplasm.